Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
(Q51483804)
scientific article published in October 2006
scientific article published in October 2006
Language:
other details
description | scientific article published in October 2006 |
External Links
(P356) |
10.1016/J.CLINTHERA.2006.10.007
|
(P698) |
17157112
|